Trendy *and* hardworking — now that's what I'm talking about.

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril ...

Synthetic microbiomes to treat disease. Sea levels may rise faster than we thought. AI for scientific researchers. All that ...

A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting ...